Aetos Pharma is a Levothyroxine Sodium Tablets USP Manufacturer in India and also Exporters in the Latin American region including countries such as Bolivia, Ecuador, Dominican Republic, Chile, Venezuela, Brazil, Colombia, Mexico, Guyana, Guatemala, Panama, Trinidad and Tobago, and El Salvador.
Levothyroxine Sodium Tablets USP Manufacturer, Exporter, and Supplier in India
Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4) and is commonly prescribed to individuals with hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormones. One of the prominent pharmaceutical companies manufacturing levothyroxine tablets is Aetos Pharma, renowned for its commitment to quality and patient well-being. In this article, we will explore the Levothyroxine Tablets produced by Aetos Pharma in various strengths/presentations of 25 mcg, 100 mcg, and 200 mcg.
Understanding Hypothyroidism and Levothyroxine Treatment
Hypothyroidism affects millions of people worldwide, and it can lead to various symptoms such as fatigue, weight gain, depression, and impaired cognitive function. Levothyroxine, the active ingredient in Aetos Pharma’s tablets, acts as a replacement for inadequate natural thyroid hormone levels, thereby alleviating the symptoms and restoring the body’s metabolic balance.
Overview of Levothyroxine Tablets by Aetos Pharma
Aetos Pharma manufactures Levothyroxine Tablets in three different strengths – 25 mcg, 100 mcg, and 200 mcg. These tablets come in oral form, allowing for easy and convenient administration. Each strength is color-coded for easy identification and differentiation:
25 mcg Levothyroxine Tablet: This tablet is usually imprinted with a specific code and color to distinguish it from other strengths. Patients requiring lower doses of levothyroxine, such as those starting treatment or needing precise dosage adjustments, are commonly prescribed the 25 mcg strength.
100 mcg Levothyroxine Tablet: The 100 mcg strength is intermediate and may be prescribed to patients requiring a moderate dose of levothyroxine. It is an essential strength in the Levothyroxine Tablet lineup and helps cater to a significant portion of the hypothyroid patient population.
200 mcg Levothyroxine Tablet: The 200 mcg strength is the highest dosage available in Aetos Pharma’s Levothyroxine Tablets. It is typically prescribed to patients with severe hypothyroidism or those who may not respond well to lower doses.
Dosage and Administration
The dosage of Levothyroxine Tablets should be determined by a qualified healthcare professional based on the patient’s individual needs, medical history, and thyroid function tests. It is essential to follow the prescribed dosage and not exceed it without proper medical guidance. The tablets are usually taken orally, preferably in the morning on an empty stomach, at least 30 minutes before breakfast. This ensures optimal absorption and effectiveness of the medication.
Quality Assurance and Safety
Aetos Pharma is committed to maintaining high standards of quality assurance and safety for all its pharmaceutical products, including Levothyroxine Tablets. The manufacturing process adheres to strict regulations and guidelines set by health authorities to ensure the final product’s efficacy, safety, and stability. Additionally, Aetos Pharma conducts rigorous quality checks, including testing the raw materials and finished products in state-of-the-art laboratories.
Possible Side Effects
While Levothyroxine is generally well-tolerated by most patients, some individuals may experience mild side effects, especially during the initial stages of treatment or when doses are adjusted. These side effects may include headaches, temporary hair loss, nervousness, palpitations, and mild digestive disturbances. It is crucial for patients to communicate any adverse reactions to their healthcare providers promptly.
Aetos Pharma Private Limited is a leading WHO-GMP EU-GMP Pharmaceuticals Manufacturer exports products to the following continents
Angola | Benin | Botswana | Burkina Faso | Burundi | Cameroon | Cape Verde | Central African Republic | Chad (Tchad) | Comoros | Republic of the Congo | Democratic Republic of the Congo | Côte d’Ivoire (Ivory Coast) | Djibouti | Equatorial Guinea | Egypt (Misr) | Eritrea | Ethiopia (Abyssinia) | Gabon | The Gambia | Ghana | Guinea | Guinea-Bissau | Kenya | Lesotho | Liberia | Libya | Madagascar | Malawi | Algeria | Mali | Mauritania | Mauritius | Morocco (Al Maghrib) | Mozambique | Namibia | Niger | Nigeria | Rwanda | São Tomé and Príncipe | Senegal | Seychelles | Sierra Leone | Somalia | South Africa | South Sudan | Sudan | Swaziland (Eswatini) | Tanzania | Togo | Tunisia | Uganda | Western Sahara | Zambia | Zimbabwe
Afghanistan | Armenia | Azerbaijan | Bahrain | Bangladesh | Bhutan | Brunei | Cambodia (Kampuchea) | Georgia | India | Indonesia | Iran | Iraq | Japan | Jordan (Al Urdun) | Kazakhstan | Kuwait | Kyrgyzstan | Laos | Lebanon (Lubnan) | Malaysia | Maldives | Mongolia | Myanmar (Burma) | Nepal | North Korea | Oman | Philippines | Qatar | Russia | Saudi Arabia | Singapore | South Korea | Sri Lanka | Syria | Tajikistan | Thailand | Turkey | Turkmenistan| Taiwan | United Arab Emirates | Uzbekistan | Vietnam | Yemen
Albania | Andorra | Austria | Belarus | Belgium | Bosnia and Herzegovina | Bulgaria | Croatia | Cyprus | Czech Republic | Denmark | Estonia | Finland | Georgia | Germany | Greece | Hungary | Iceland | Republic of Ireland | Italy | Kosovo | Latvia | Liechtenstein | Lithuania | Luxembourg | North Macedonia | Malta | Moldova | Monaco | Montenegro | Netherlands | Norway | Poland | Portugal | Romania | San Marino | Serbia | Slovakia | Slovenia | France | Spain | Sweden | Switzerland | Ukraine | United Kingdom
Canada | United States of America | Navassa Island | Puerto Rico | US Virgin Islands | Guam | American Samoa
Brazil | Argentina | Bolivia | Chile | Colombia | Ecuador | Falkland Islands | French Guiana | Guyana | Paraguay | Peru | South Georgia and the South Sandwich Islands | Suriname | Uruguay | Venezuela | Belize | Costa Rica | El Salvador | Guatemala | Honduras | Nicaragua | Panama | Dominican Republic | Mexico | Haiti | Antigua and Barbuda | Bahamas | Barbados | Cuba | Dominica | Grenada | Jamaica | Saint Lucia | Saint Kitts and Nevis | Saint Vincent and the Grenadines | Trinidad and Tobago
Australia | Fiji | New Zealand | Federated States of Micronesia | Kiribati | Marshall Islands | Nauru | Palau | Papua New Guinea | Samoa | Solomon Islands | Tonga | Tuvalu | Vanuatu